Results 101 to 110 of about 14,806 (151)

Clinical utility of anti-cytosolic 5'-nucleotidase 1A antibody in idiopathic inflammatory myopathies. [PDF]

Ann Clin Transl Neurol, 2021
Ikenaga C, Findlay AR, Goyal NA, Robinson S, Cauchi J, Hussain Y, Wang LH, Kershen JC, Beson BA, Wallendorf M, Bucelli RC, Mozaffar T, Pestronk A, Weihl CC.   +13 more
europepmc   +1 more source

Identification of 6‑Aryl-7-Deazapurine Ribonucleoside Phosphonates as Inhibitors of Ecto-5'-Nucleotidase (CD73). [PDF]

ACS Pharmacol Transl Sci
Šímová M, Ormsby T, Šinkevičiu̅tė U, Sirotová Veselovská L, Čermáková K, Hadzima M, Bartoň L, Staňurová J, Kramná A, Šácha P, Tichý M, Hocek M, Konvalinka J, Blazkova K.   +13 more
europepmc   +1 more source

Targeting ecto-5'-nucleotidase (CD73) and cAMP alleviates carotid body hyperactivity and reduces blood pressure in chronically hypoxic rats. [PDF]

J Physiol
Nathanael D, Coney AM, Alotaibi D, Kumar P, Holmes AP.   +4 more
europepmc   +1 more source

Fluorescent Probes for Ecto-5'-nucleotidase (CD73). [PDF]

ACS Med Chem Lett, 2020
Schmies CC, Rolshoven G, Idris RM, Losenkova K, Renn C, Schäkel L, Al-Hroub H, Wang Y, Garofano F, Schmidt-Wolf IGH, Zimmermann H, Yegutkin GG, Müller CE.   +12 more
europepmc   +1 more source

Substrate binding modes of purine and pyrimidine nucleotides to human ecto-5'-nucleotidase (CD73) and inhibition by their bisphosphonic acid derivatives. [PDF]

Purinergic Signal, 2021
Scaletti E, Huschmann FU, Mueller U, Weiss MS, Sträter N.   +4 more
europepmc   +1 more source

Ecto-5'-nucleotidase/CD73 reduces COX-2 expression in activated macrophages. [PDF]

Sci Rep
Rahman MM, Sircar A, Lakhina S, Kumar P, Gupta RD, Akundi RS.   +5 more
europepmc   +1 more source

Cytosolic 5'-Nucleotidase II Is a Sensor of Energy Charge and Oxidative Stress: A Possible Function as Metabolic Regulator. [PDF]

Cells, 2021
Pesi R, Allegrini S, Balestri F, Garcia-Gil M, Cividini F, Colombaioni L, Jordheim LP, Camici M, Tozzi MG.   +8 more
europepmc   +1 more source

Potent Competitive Inhibitors of Ecto-5'-nucleotidase (CD73) based on 6‑(Het)aryl-7-deazapurine Ribonucleoside 5'‑<i>O</i>‑Bisphosphonates. [PDF]

ACS Pharmacol Transl Sci
Šinkevičiu̅tė U, Šímová M, Staník R, Poštová Slavětínská L, Blažková K, Šácha P, Lepšík M, Řezáč J, Konvalinka J, Ormsby T, Tichý M, Hocek M.   +11 more
europepmc   +1 more source

Ecto-5'-nucleotidase (Nt5e/CD73)-mediated adenosine signaling attenuates TGFβ-2 induced elastin and cellular contraction.

Am J Physiol Cell Physiol, 2023
Cuevas RA, Wong R, Joolharzadeh P, Moorhead WJ, Chu CC, Callahan J, Crane A, Boufford CK, Parise AM, Parwal A, Behzadi P, St Hilaire C.   +11 more
europepmc   +1 more source

Ectonucleoside triphosphate diphosphohydrolases and ecto-5'-nucleotidase in purinergic signaling: how the field developed and where we are now. [PDF]

Purinergic Signal, 2021
Zimmermann H.
europepmc   +1 more source